[go: up one dir, main page]

HK1183011A - Agonists of gpr40 - Google Patents

Agonists of gpr40 Download PDF

Info

Publication number
HK1183011A
HK1183011A HK13110422.2A HK13110422A HK1183011A HK 1183011 A HK1183011 A HK 1183011A HK 13110422 A HK13110422 A HK 13110422A HK 1183011 A HK1183011 A HK 1183011A
Authority
HK
Hong Kong
Prior art keywords
gpr40
compounds
agonists
treatment
activity
Prior art date
Application number
HK13110422.2A
Other languages
Chinese (zh)
Inventor
Jagannath Madanahalli Ranganath Rao
Nagarajan Arumugam
Mohd Mudabbir Ansari
Chandrasekhar Gudla
Shanmugam Pachiyappan
Manivannan Ramalingam
Jenson George
George Fernanda Arul
Y Kenchegowda Bommegowda
Sathesh Kumar Angupillai
Ramamoorthy Kottamalai
Pradeep Jidugu
D Shivanageshwara Rao
Original Assignee
Connexios Life Sciences Pvt. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connexios Life Sciences Pvt. Ltd. filed Critical Connexios Life Sciences Pvt. Ltd.
Publication of HK1183011A publication Critical patent/HK1183011A/en

Links

Abstract

The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are therefore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders related to GPR40 activity.
HK13110422.2A 2010-07-23 2011-07-20 Agonists of gpr40 HK1183011A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2110/CHE/2010 2010-07-23
US61/389,508 2010-10-04

Publications (1)

Publication Number Publication Date
HK1183011A true HK1183011A (en) 2013-12-13

Family

ID=

Similar Documents

Publication Publication Date Title
MY161088A (en) Agonists of gpr40
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
EP4414376A3 (en) Novel depsipeptide and uses thereof
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
WO2012177844A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2012051318A8 (en) Sulphonamide compounds and methods of making and using same
WO2011082270A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
UA109661C2 (en) PHARMACEUTICAL COMPOSITION OF TRAMADOL AND COXYBY CO-CRYSTALS
HK1212348A1 (en) Autotaxin inhibitors
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
MY165624A (en) N-acylsulfonamide apoptosis promoters
EP3626253A3 (en) Stable formulations of linaclotide
WO2012118812A3 (en) Substituted 6,5-fused bicyclic heteroaryl compounds
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
WO2012154679A8 (en) Tricyclic pyrazole sulfonamide compounds and methods of making and using same
WO2011123678A3 (en) Substituted benzo-pyrido-triazolo-diazepine compounds
WO2013061004A8 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
WO2014035846A3 (en) Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use
MX2013002118A (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.